The number of cancer mutations in FGFR KDs that have been comprehensively assessed for their functional impact is limited, with the most emphasis being on replacements at positions corresponding to FGFR3 K650 and mutation corresponding to FGFR3 N540K [14, 21, 23, 30, 31]. The gene discussed is FGFR3; the disease is cancer.